MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makriyannis, A.
Right arrow Articles by el-Khateeb, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makriyannis, A.
Right arrow Articles by el-Khateeb, S.

Hallucinogenic receptor models: interaction of imidazolium chloride with amphetamine analogs

A Makriyannis, CM DiMeglio, AP DeJong and S el-Khateeb

School of Pharmacy, University of Connecticut, Storrs 06269-2092.

The interactions of several hallucinogenic phenethylamines with the biologically relevant electron acceptor imidazolium chloride have been investigated by monitoring phenethylamine 1H NMR chemical shift changes upon complex formation. Methoxy- and methylenedioxy-substituted phenethylamines interact with imidazolium chloride to form weak charge- transfer complexes that have a relatively narrow range of association constants. The results indicate the formation of a ternary complex in which a chloride ion is hydrogen bonded to a N+H side chain proton of the drug and a NH imidazolium proton. The imidazolium ring is positioned above a nonsubstituted ortho-position of the aromatic ring. Spectral assignment of the two diastereotopic benzylic protons allowed the geometry of the complex to be defined in more detail. Complexation occurs preferentially on that side of the phenethylamine molecule that allows the side chain alpha-methyl group to face away from the chloride ion and the imidazolium ring. The drug molecule exists in the complex in the preferred trans conformation. The biological relevance of this model is discussed.

Volume 43, Issue 1, pp. 78-83, 01/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics